Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Hyaluronic acid as a biomarker of lung cancer diagnosis and prognosis

June 9, 2011

New clinical data presented on lurasidone in schizophrenia

June 9, 2011

LGD-4033 well tolerated in healthy volunteers at multiple doses

June 9, 2011

Yokukansan reduces delirium after acute ischemic stroke

June 9, 2011

Interim data from first-in-human trial of Pfizer's CVX-241 support safety in advanced solid tumors

June 9, 2011

New clinical data presented on LY-2127399 in rheumatoid arthritis and multiple myeloma

June 9, 2011

New PARP-1 inhibitor JI-1260 is a candidate for stroke therapy

June 8, 2011

VTX-2337 exhibits safety/tolerability in phase I trial in advanced solid tumors

June 8, 2011

BAY-80-6946 is well tolerated in first-in-human trial in advanced solid tumors

June 8, 2011

Sunitinib has limited efficacy in advanced adrenocortical carcinoma in phase II trial

June 8, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026
SERCA inhibitor shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, researchers...